Nationally Notifiable Infectious Diseases and Conditions, United States: Weekly Tables

Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending June 22, 2024 (Week 25)
Reporting Area Chlamydia trachomatis infection §
Current weekPrevious 52 weeks Max †Cum YTD 2024 †Cum YTD 2023 †
U.S. Residents, excluding U.S. Territories 12,143 35,080 636,088 791,602
New England 477 885 18,090 20,662
Connecticut - 0 - 1,155
Maine 31 80 1,295 1,404
Massachusetts 376 642 13,154 13,660
New Hampshire - 79 1,016 1,351
Rhode Island 70 389 2,012 2,420
Vermont - 35 613 672
Middle Atlantic 932 4,381 87,458 95,601
New Jersey - 788 15,360 17,210
New York (excluding New York City) 712 957 18,675 19,960
New York City 218 1,565 29,424 31,921
Pennsylvania 2 1,166 23,999 26,510
East North Central 1,864 4,539 78,336 107,970
Illinois 76 1,289 15,321 31,781
Indiana 442 726 14,648 16,769
Michigan 305 1,019 13,833 20,282
Ohio 622 1,220 23,431 26,973
Wisconsin 419 533 11,103 12,165
West North Central 1,112 2,132 41,986 47,348
Iowa 178 313 5,688 6,686
Kansas 144 304 5,250 6,519
Minnesota 332 485 9,611 10,654
Missouri 347 746 14,172 15,128
Nebraska 71 249 3,912 4,331
North Dakota 40 87 1,442 1,671
South Dakota - 118 1,911 2,359
South Atlantic 2,494 12,264 160,584 183,803
Delaware 78 227 2,565 2,792
District of Columbia - 200 3,074 4,088
Florida - 6,926 50,342 54,224
Georgia 833 1,534 29,919 35,900
Maryland - 1,009 13,420 16,396
North Carolina 4 1,433 25,077 32,209
South Carolina 622 820 15,734 16,008
Virginia 899 934 18,442 20,093
West Virginia 58 115 2,011 2,093
East South Central 1,043 1,974 28,513 51,850
Alabama 615 895 15,451 16,488
Kentucky 292 574 7,374 7,565
Mississippi 136 1,004 5,688 9,924
Tennessee - 429 - 17,873
West South Central 703 4,737 75,984 109,003
Arkansas 180 394 7,440 9,013
Louisiana 315 892 15,376 17,562
Oklahoma 52 383 4,746 9,054
Texas 156 3,277 48,422 73,374
Mountain 1,286 2,669 47,766 56,192
Arizona 372 929 17,991 19,558
Colorado 437 856 11,289 12,282
Idaho 100 145 2,487 2,832
Montana 32 98 1,557 1,741
Nevada 177 374 5,422 8,124
New Mexico 17 253 3,459 5,454
Utah 151 255 4,861 5,302
Wyoming - 52 700 899
Pacific 2,232 5,058 97,371 119,173
Alaska 64 125 2,380 2,524
California 1,896 3,909 79,893 92,666
Hawaii - 137 - 2,998
Oregon 272 382 6,717 7,231
Washington - 609 8,381 13,754
U.S. Territories - 119 638 2,320
American Samoa - 0 - -
Commonwealth of Northern Mariana Islands - 0 - -
Guam - 0 - -
Puerto Rico - 119 638 2,320
U.S. Virgin Islands - 0 - -
Non-U.S. Residents 1 3 11 28
Total 12,144 35,123 636,737 793,950
  • U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
  • -: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
  • N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
  • NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
  • NP: Nationally notifiable but not published.
  • NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
  • Cum: Cumulative year-to-date counts.
  • * Case counts for reporting years 2023 and 2024 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://www.cdc.gov/nndss/data-statistics/readers-guides/.
  • † Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
  • § Beginning in January 2022, only confirmed cases are published to align with the approved CSTE position statement 21-ID-06, whereas in previous years, all case classification statuses were published. This change may cause a decrease in published case counts when compared to previous years.